Pädiatrie up2date, Table of Contents Pädiatrie up2date 2012; 07(04): 343-365DOI: 10.1055/s-0032-1325876 Neuropädiatrie/Psychiatrie © Georg Thieme Verlag KG Stuttgart · New York Erworbene neuromuskuläre Erkrankungen Rudolf Korinthenberg Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Engel AG, Franzini-Armstrong C eds. Myology. 2nd. ed. New York: McGraw-Hill; 1994 2 Jones HR, de Vivo DC, Darras BT eds. Neuromuscular disorders of infancy, childhood, and adolescence. A clinician's approach. Amsterdam: Butterworth-Heinemann; 2004 3 Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366: 1653-1666 4 Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barre syndrome: a prospective multicentre study. Neuropediatrics 2007; 38: 10-17 5 Korinthenberg R, Gold R, Felderhoff-Müser U. Guillain-Barré-Syndrom im Kindes- und Jugendalter. Leitlinie der Gesellschaft für Neuropädiatrie. . http://www.awmf.org/leitlinien.html 6 Asbury AK. New concepts of Guillain-Barré syndrome. J Child Neurol 2000; 15: 183-191 7 Raphaël JC, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2002; CD001798 8 Cortese I, Chaudhry V, So YT et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011; 76: 294-300 9 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 2010; CD002063 10 Gürses N, Uysal S, Cetinkaya F et al. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Scand J Infect Dis 1995; 27: 241-243 11 Korinthenberg R, Schessl J et al. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial. Pediatrics 2005; 116: 8-14 12 Vajsar J, Fehlings D, Stephens D. Long-term outcome in children with Guillain-Barre syndrome. J Pediatr 2003; 142: 305-309 13 Tekgul H, Serdaroglu G, Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillain-Barre syndrome in children. Pediatr Neurol 2003; 28: 295-299 14 Korinthenberg R. Chronic inflammatory demyelinating polyradikuloneuropathy in children and their response to treatment. Neuropediatrics 1999; 30: 190-196 15 Kiefer R. Krankheiten peripherer Nerven. Stuttgart: Kohlhammer; 2011 16 Alb M, Hirner S, Luecke T. Critical illness polyneuropathy and myopathy. Pathogenesis and diagnostic. Anaesthesiol Intensivmed Notfallmed Schmerzther 2007; 42: 250-258 17 Kuhlenbäumer G, Stögbauer F et al. Diagnostic guidelines for hereditary neuralgic amyotrophy or heredofamilial neuritis with brachial plexus predilection. On behalf of the European CMT Consortium. Neuromuscul Disord 2000; 10: 515-517 18 Pitaro J, Waissbluth S, Daniel SJ. Do children with Bell's palsy benefit from steroid treatment? A systematic review. Int J Pediatr Otorhinolaryngol 2012; 76: 921-926 19 Salinas RA, Alvarez G et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010; CD001942 20 Blankenburg M, Kraemer N, Hirschfeld G et al. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment. Diabet Med 2012; [Epub ahead of print] 21 Parr JR, Jayawant S. Childhood myasthenia: clinical subtypes and practical management. Dev Med Child Neurol 2007; 49: 629-635 22 Schneider-Gold C, Toyka KV. Myasthenia gravis: Pathogenese und Immuntherapie. Dtsch Arztebl 2007; 104: A 420-426 23 Schneider-Gold C, Gajdos P et al. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005; CD002828 24 Seybold ME. Thymectomy in childhood myasthenia gravis. Ann NY Acad Sci 1998; 841: 731-741 25 Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 7-15 26 Rider LG, Miller FW. Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheumatic Disease Clinics of North America 1997; 23: 619-655 27 Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 2006; 16: 223-236 28 Sieb JP, Gillessen Th. Iatrogenic and toxic myopathies. Muscle Nerve 2002; 27: 142-156 29 Watemberg N, Leshner RL et al. Acute pediatric rhabdomyolysis. J Child Neurol 2000; 15: 222-227 30 Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr 2004; 16: 206-210
